SlideShare a Scribd company logo
Newborn
Child Health
Regional Review
What Indicators project?
15
20
28
32
16
21
27
30
0
5
10
15
20
25
30
35
ENMR NMR IMR UNDER-5
SRS-2020
INDIA BIHAR
2
19.5
3
25.5
1
10
100
TFR CBR
103
130
-10
10
30
50
70
90
110
130
MMR
SRS 2020 SRS 2019
Child Mortality Trend in Bihar
27 25 23 23 22 23 21 21 20 18 16
31 29 28 28 27 28 27 28 25 23 21
48
44 43 42 42 42
38 35
32
29
27
64
59
57 54 53 48
43 41
37
34
30
2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
ENMR NMR IMR U5MR Source : SRS
69
58
37
59
47
30
32 28 20
U5MR* IMR NMR
India (2005-2019)
2005 2010 2020
54%
reduction
75
61
32
64
48
31
30 27 21
U5MR* IMR NMR
Bihar (2005-2019)
2005 2010 2020
52%
reduction 46%
reduction
60%
reduction 56%
reduction 34%
reduction
NCH Indicators and Target
Child Health Indicator India Bihar NHP 2017 SDG 2030
Neonatal Mortality Rate 20 (SRS, 2020) 21 (SRS, 2020) 16 by 2025 <12
Infant Mortality Rate 28 (SRS, 2020) 27 (SRS, 2020) 28 by 2019 -
Under 5Mortality Rate 32 (SRS, 2020) 30 (SRS, 2020) 23 by 2025 ≤25
NCH:
Key Programs
 Newborn Care
• Special Newborn Care Unit (SNCU) at DHs
• Newborn Stabilization Unit (District) at FRUs
• Newborn Care Corner (NBCC) at all delivery points
 Paediatric Care
• Paediatric OPD
• Paediatric IPD
• Nutrition Rehabilitation Centre (NRC)
Facility-Based Care
• Home Based Newborn Care (HBNC)
• Home Based Young Child Care (HBYC)
• Anemia Mukt Bharat (AMB)
Community-Based Care
• Child Death Review
• Regular Monthly Review at all levels
Review Mechanism
• MusQan
Quality Standard
Special
Newborn Care
Unit (SNCU)
SNCU: Admission and Outcome profile
• Total Admission in the previous quarter in the Region (Sum of all districts)
(Jul-Sep 2022) : 200
[CELLRANGE], 80 [CELLRANGE], 70 [CELLRANGE], 30
[CELLRANGE], 20
Inborn Outborn Private Home
[CELLRANGE]
48
[CELLRANGE]
16
[CELLRANGE]
8
[CELLRANGE]
8
Inborn
[CELLRANGE], 42
[CELLRANGE], 14
[CELLRANGE], 7
[CELLRANGE], 7
Outborn
Discharged Referred LAMA Death
[CELLRANGE], 18
[CELLRANGE], 6
[CELLRANGE], 3
[CELLRANGE], 3
Private
[CELLRANGE], 12
[CELLRANGE], 4
[CELLRANGE], 2
[CELLRANGE], 2
Home
Case type and Outcome
[CELLRANGE]
20
[CELLRANGE]
5
[CELLRANGE]
3
[CELLRANGE]
2
Jaundice
30
[CELLRANGE
]
70
[CELLRANGE
]
50
[CELLRANGE
]
30
[CELLRANGE
]
20
[CELLRANGE
]
10
[CELLRANGE
]
10
[CELLRANGE
]
10
Asphyxia
RDS
Jaundice
Seizure
VLBW
Preterm
Others
[CELLRANGE]
10
[CELLRANGE]
5
[CELLRANGE]
3
[CELLRANGE]
2
Seizure
20
Discharged Referred LAMA Death
[CELLRANGE]
7
[CELLRANGE]
2
[CELLRANGE]
1
[CELLRANGE]
2
VLBW
10
[CELLRANGE]
6
[CELLRANGE]
1
[CELLRANGE]
1
[CELLRANGE]
2
Preterm
10
[CELLRANGE]
38
[CELLRANGE]
16
[CELLRANGE]
8
[CELLRANGE]
8
Asphyxia
70
[CELLRANGE]
28
[CELLRANGE]
6
[CELLRANGE]
8
[CELLRANGE]
8
RDS
50
Birth weight and Outcome
• Total Admission during the period: 200
[CELLRANGE]
68
[CELLRANGE]
16
[CELLRANGE]
8
[CELLRANGE]
8
Good Weight
[CELLRANGE], 100 [CELLRANGE], 50 [CELLRANGE], 50
Good Weight (≥2500 gm)
LBW (<2500gm)
LBW (≤1800gm)
[CELLRANGE]
28
[CELLRANGE]
6
[CELLRANGE]
8
[CELLRANGE]
8
LBW<1800gm
[CELLRANGE]
28
[CELLRANGE]
6
[CELLRANGE]
8
[CELLRANGE]
8
LBW <2500 gm
Discharged Referred LAMA Death
70
100
Rational Use of Antibiotics
Newborn with Sepsis Newborn given Antibiotics
[CELLRANG
E], 50
[CELLRANG
E], 100
[CELLRANG
E], 25
[CELLRANG
E], 25
Duration of Stay at SNCU
>6 days 4-6 days 1-3 days <1 day
Duration of Stay and Rational use of Antibiotics
Delivery Point and SNCU Linkage
[CELLRANGE]
4
[CELLRANGE]
2
[CELLRANGE]
1
[CELLRANGE]
0
[CELLRANGE]
0
[CELLRANGE]
3
[CELLRANGE]
4
[CELLRANGE]
1
[CELLRANGE]
1
[CELLRANGE]
1
[CELLRANGE]
1
[CELLRANGE]
10
[CELLRANGE]
2
[CELLRANGE]
1
[CELLRANGE]
3
[CELLRANGE]
1
[CELLRANGE]
1
[CELLRANGE]
3
[CELLRANGE]
1
[CELLRANGE]
5
[CELLRANGE]
1
[CELLRANGE]
2
[CELLRANGE]
2
[CELLRANGE]
1
[CELLRANGE]
3
[CELLRANGE]
4
[CELLRANGE]
5
[CELLRANGE]
1
[CELLRANGE]
1
[CELLRANGE]
0
0
2
4
6
8
10
12
PHC
1
PHC
2
PHC
3
PHC
4
PHC
5
PHC
6
PHC
7
PHC
8
PHC
9
PHC
10
PHC
11
PHC
12
PHC
13
PHC
14
PHC
15
PHC
16
PHC
17
PHC
18
PHC
19
PHC
20
PHC
21
PHC
22
PHC
23
PHC
24
PHC
25
PHC
26
PHC
27
PHC
28
PHC
29
PHC
30
No. of Cases referred to SNCU
No. of Cases referred to SNCU
Performance: SNCU wise
Period: Jul-Sep 2022
SNCU : HR Availability
3
[CELLRANGE]
3
[CELLRANGE]
13
SNCU-1
Paediatrician GMO Nurse
3
[CELLRANGE]
3
[CELLRANGE]
13
SNCU-2
Paediatrician GMO Nurse
3
[CELLRANGE]
3
[CELLRANGE]
13
SNCU-3
Paediatrician GMO Nurse
As per DoH, Bihar (Letter No. 466 Dated 12.08.2014) Posts of 1 Paediatrician, 3 GMO and 13 Grade-A Nurse have
been created for each SNCU.
SNCU Performance: Outcome
[CELLRANGE]
68
[CELLRANGE]
16
[CELLRANGE]
8
[CELLRANGE]
8
SNCU-1
Discharged Referred LAMA Death
[CELLRANGE]
68
[CELLRANGE]
16
[CELLRANGE]
8
[CELLRANGE]
8
SNCU-3
Discharged Referred LAMA Death
[CELLRANGE]
68
[CELLRANGE]
16
[CELLRANGE]
8
[CELLRANGE]
8
SNCU-2
Discharged Referred LAMA Death
No. of Treated Cases: 100 No. of Treated Cases: 100 No. of Treated Cases: 100
SNCU: Bed Utilization
[CELLRANGE]
60
[CELLRANGE]
50
[CELLRANGE]
60
[CELLRANGE]
50
[CELLRANGE]
50
[CELLRANGE]
50
[CELLRANGE]
60
[CELLRANGE]
60
[CELLRANGE]
60
44
46
48
50
52
54
56
58
60
62
SNCU-1 SNCU-2 SNCU-3
Jul-22 Aug-22 Sep-22
Desirable No. of Admission=6 admissions per bed per month
Outcome of Low Birth weight (<1800gm) babies
[CELLRANGE]
70
[CELLRANGE]
14
[CELLRANGE]
10
[CELLRANGE]
6
SNCU-1
[CELLRANGE]
70
[CELLRANGE]
14
[CELLRANGE]
10
[CELLRANGE]
6
SNCU-2
[CELLRANGE]
70
[CELLRANGE]
14
[CELLRANGE]
10
[CELLRANGE]
6
SNCU-3
Outcome of Good weight (>2500gm) babies
[CELLRANGE]
70
[CELLRANGE]
14
[CELLRANGE]
10
[CELLRANGE]
6
SNCU-1
[CELLRANGE]
70
[CELLRANGE]
14
[CELLRANGE]
10
[CELLRANGE]
6
SNCU-2
[CELLRANGE]
70
[CELLRANGE]
14
[CELLRANGE]
10
[CELLRANGE]
6
SNCU-3
SNCU: Rational use of antibiotics
60
50
60
[CELLRANGE]
50
[CELLRANGE]
50
[CELLRANGE]
50
44
46
48
50
52
54
56
58
60
62
SNCU-1 SNCU-2 SNCU-3
No. of Sepsis Cases No. of babies treated with antibiotics
Functionality and utilization of CPAP machine
Sl.
No.
Name of SNCU No. of
CPAP
Machine
Available
No. of
CPAP
Machine
Functional
No. of
babies with
birth
weight
<1800gm
No. of
babies with
<34 Weeks
of gestation
No. of
babies with
RDS
admitted
during the
period
No. of
babies with
RDS
managed
using CPAP
during the
period
1
2
3
4
SNCU Performance: Other key areas
Review Point SNCU-1 SNCU-2 SNCU-3 SNCU-4
1. Daily Round of Paediatrician in all 3 shifts (Yes/No)
Morning Shift Yes Yes Yes No
Evening Shift Yes Yes Yes No
Night Shift Yes Yes Yes No
Round Register maintained properly No Yes Yes No
2. Equipment
Mapping of equipment completed Yes Yes Yes No
3. Availability of drugs and logistics
No Stockouts during the period
(Yes/No)
Yes Yes Yes No
4. Availability of Lab investigations (Serum bilirubin, Plasma glucose, Serum creatinine, Blood count, Platelet, C reactive protein,
Prothrombin time, Blood gas analysis with PH measurement analysis.)
All Lab investigations available Yes Yes Yes Yes
Newborn
Stabilization
Unit (NBSU)
Performance
Period: Jul-Sep 22
8
5
5
5
All NBSU
LBW (<2500 gm)
Birth Weight <1800 gm
Jaundice Cases
Others
NBSU: Admission Profile
Sl. No. Name of NBSU Admission
LBW (<2500gm) Birth Weight
(<1800gm)
Jaundice Cases Others
1 NBSU-1
2 NBSU-2
3 NBSU-3
4 NBSU-4
5 NBSU-5
6 NBSU-6
7 NBSU-7
8
5
5
5
All NBSU
Discharged
Referred
LAMA
Death
NBSU: Outcome Profile
Sl.
No.
Name of NBSU Admission Vs Outcome
Functional
(Yes/No)
Total
Admission
Discharge Referred LAMA Death
1 NBSU-1 10 4 (80%) 3 (30%) 2 (20%) 1 (10%)
2 NBSU-2
3 NBSU-3
4 NBSU-4
5 NBSU-5
6 NBSU-6
7 NBSU-7
Newborn Care
Corner (NBCC)
NBCC: Admission Profile
Sl.
No.
Name of District Weight and Maturity
Total Live
Birth
LBW
(<2500gm)
Birth
Weight
(≤2000gm)
Birth
Weight
<1800gm)
<34 Weeks <37 Weeks Cases
managed at
NBCC
Cases
Referred to
higher
centre
Desired Action Initial
management
at NBCC
followed by
quality HBNC
Initial
management
at NBCC
followed by
quality HBNC
Referral after
stabilization
1 District-1
2 District-2
3 District-3
4 District-4
5 District-5
6 District-6
7 District-7
Management of neonatal complications at NBCC
14
15
14
15
[CELLRANGE]
5
[CELLRANGE]
6 [CELLRANGE]
5
[CELLRANGE]
8
[CELLRANGE]
3
[CELLRANGE]
4
[CELLRANGE]
2
[CELLRANGE]
3
[CELLRANGE]
2
[CELLRANGE]
2
[CELLRANGE]
3
[CELLRANGE]
5
0
2
4
6
8
10
12
14
16
District-1 District-2 District-3 District-4
NBCC Performance
Sum of Live Births at all Delivery Points No. of Cases identified with neonatal complications Cases manged at NBCC Cases Referred
NBCC: Do’s and Don’ts
Do’s
• Always wash your hands before handling the baby
• Rooming in of baby with the mother
• Keep the baby with the mother
• Keep the baby warm
• Take extra care to maintain baby’s temperature is
preterm and LBW baby
• Keep the cord dry and clean
• Breast fed the baby exclusively
• Early initiation of breast feeding is essential for a good
reflex action
• Any signs/symptoms of complications must be referred
and attended to by a doctor
• The care provider should observe every 2 hours in the
first 6 hours and every 6 hours from 6-24 hours after
delivery
• If the newborn is LBW then at least three additional visits
should be ensured
Don’ts
• Do not keep all babies as a routine under the radiant
warmer
• Do not delay breast feeding beyond half an hour as that
may lead to rapid decrease in suckling reflex of the rapid
decrease in suckling reflex of the baby
• Do not use prelacteals even water
• Do not apply anything on the cord
• Do not bathe the newborn for 24hrs after birth
• Do not forget to undertake routine checkup
Nutritional
Rehabilitation
Centre (NRC)
NRC: ELA Vs Admission
60
50
60 60 60
[CELLRANGE]
50
[CELLRANGE]
50
[CELLRANGE]
50
[CELLRANGE]
50
[CELLRANGE]
50
44
46
48
50
52
54
56
58
60
62
NRC-1 NRC-2 NRC-3 NRC-4 NRC-5
ELA Admission
NRC: Average Duration of Stay
21
14
10
5
14
0
5
10
15
20
25
NRC-1 NRC-2 NRC-3 NRC-4 NRC-5
Average Duration of Stay
NRC: Availability of Diet and Drugs
Sl.
No.
Name of NRC Diet being provided as
per the guideline
Drugs and other
logistics available as
per the guideline
1 NRC-1 Yes Yes
2 NRC-2 No Yes
3 NRC-3 Yes Yes
4 NRC-4 Yes Yes
5 NRC-5 Yes No
Home Based
Newborn Care
(HBNC)
HBNC: Performance
3,000 3,000 3,000 3,000 3,000
5,000 5,000 5,000 5,000 5,000
3,000
2,500
2,700
3,000 3,000
4,000
5,000
4,000
3,000 3,000
[CELLRANGE]
200
[CELLRANGE]
150
[CELLRANGE]
125
[CELLRANGE]
100
[CELLRANGE]
100
0
1000
2000
3000
4000
5000
6000
District-1 District-2 District-3 District-4 District-5
#REF! No. of ASHA Live Birth No. of ASHAs having new HBNC Kit Cases visited by ASHA Sick Children identified by ASHA
HBNC: Supportive Supervision
5,000 5,000 5,000 5,000 5,000
[CELLRANGE]
4,000
[CELLRANGE]
5,000
[CELLRANGE]
4,000 [CELLRANGE]
3,000
[CELLRANGE]
3,000
[CELLRANGE]
400 [CELLRANGE]
250
[CELLRANGE]
300
[CELLRANGE]
500
[CELLRANGE]
450
[CELLRANGE]
10
[CELLRANGE]
15
[CELLRANGE]
30
[CELLRANGE]
25
[CELLRANGE]
50
[CELLRANGE]
5 [CELLRANGE]
3
[CELLRANGE]
10
[CELLRANGE]
12
[CELLRANGE]
25
1
10
100
1,000
10,000
District-1 District-2 District-3 District-4 District-5
Live Birth Cases visited by ASHA Cases visited by ASHA Faciliatators Cases vistited by Block level Officers Cases vistited by district level Officers
HBNC
• Availability of HBNC Kit
• Quality of home visit by the ASHA using HBNC Kit
• Supportive Supervision by ASHA Facilitators
• Timely payment
• Review of the program at all levels
Home Based Young Child
Care (HBYC)
Training of ASHAs on HBYC
2,000
2,500
3,000
2,000
2,300
[CELLRANGE]
1,500
[CELLRANGE]
1,200
[CELLRANGE]
2,000
[CELLRANGE]
2,000
[CELLRANGE]
230
-
500
1,000
1,500
2,000
2,500
3,000
3,500
District-1 District-2 District-3 District-4 District-5
No. of ASHA-Target No. of ASHA-Trained
HBYC: Visit by ASHA and Payment
2,000
2,500
3,000
2,000
2,300
[CELLRANGE]
1,500
[CELLRANGE]
1,200
[CELLRANGE]
2,000
[CELLRANGE]
2,000
[CELLRANGE]
230
[CELLRANGE]
1,000
[CELLRANGE]
1,000
[CELLRANGE]
1,500
[CELLRANGE]
1,500
[CELLRANGE]
100
-
500
1,000
1,500
2,000
2,500
3,000
3,500
District-1 District-2 District-3 District-4 District-5
ASHA-Trained on HBYC ASHA-Started visit ASHA-Received Payement for atleast 1 case
Child Death Review (CDR)
CDR
• Reporting: Timely, Completeness, Correctness
• Review of reported cases as per the CDSR guideline
• Online Reporting on the MPCDSR Portal
CDR: Reporting and Review
500
300
400
500 500
[CELLRANGE]
25
[CELLRANGE]
55
[CELLRANGE]
22
[CELLRANGE]
35
[CELLRANGE]
32
[CELLRANGE]
12
[CELLRANGE]
12
[CELLRANGE]
13
[CELLRANGE]
15
[CELLRANGE]
15
[CELLRANGE]
5
[CELLRANGE]
6
[CELLRANGE]
7
[CELLRANGE]
8
[CELLRANGE]
9
1
10
100
1000
District-1 District-2 District-3 District-4 District-5
ELA-Child Death Reported on HMIS Reported on CDR Format Detailed Investigation
MusQan: Gap Assessment
Sl. No. Name of District Credential (Login ID and
Password) Received from
the state
(Yes/No)
Online Reporting started
(Yes/No)
1 District-1 Yes Yes
2 District-2 Yes No
3 District-3 Yes Yes
4 District-4 No No
5 District-5 Yes Yes
MusQan
Progress Update
Progress on MusQan initiative
Sl.
No.
Name of District Facility identified for
QI as per MusQan
Baseline
Assessment
Completed using
MusQan Checklist
Nodal Officer
Nominated
(Yes/No)
1 District-1 Yes Yes Yes
2 District-2 Yes No Yes
3 District-3 Yes Yes Yes
4 District-4 No No Yes
5 District-5 Yes Yes Yes

More Related Content

Similar to NCH_Review_Regional Level (003).pptx

Mternal death review lecture by dr. evelina r. castro 102413
Mternal death review lecture by dr. evelina r. castro   102413Mternal death review lecture by dr. evelina r. castro   102413
Mternal death review lecture by dr. evelina r. castro 102413
Jesart De Vera
 
Pead neonatal jaundice
Pead neonatal jaundicePead neonatal jaundice
Pead neonatal jaundice
nur amalina aminuddin baki
 
Public Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy LecturePublic Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy Lecture
Dr Gary Kerr
 
Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...
Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...
Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...
John Blue
 
H1N1_Ppt.ppt
H1N1_Ppt.pptH1N1_Ppt.ppt
H1N1_Ppt.ppt
VaibhavDeshpande67
 
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...
Interesting Update on  Recurrent  Miscarriage  for Indian Gynaecologoists   D...Interesting Update on  Recurrent  Miscarriage  for Indian Gynaecologoists   D...
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...
Lifecare Centre
 
Mu (1)
Mu (1)Mu (1)
Mu (1)
鋒博 蔡
 
Mu (2)
Mu (2)Mu (2)
Mu (2)
鋒博 蔡
 
Mu
MuMu
Mu
MuMu
Mu
MuMu
Mu
MuMu
Is there a place for progesterone in the management of miscarriage?
Is there a place for progesterone in the management of miscarriage?Is there a place for progesterone in the management of miscarriage?
Is there a place for progesterone in the management of miscarriage?
drmattprior
 
Fever in Children - A Review
Fever in Children - A ReviewFever in Children - A Review
Fever in Children - A Review
Brad Sobolewski
 
ADBHUT MATRATVA ANTENATAL SCREENING
ADBHUT MATRATVA ANTENATAL SCREENINGADBHUT MATRATVA ANTENATAL SCREENING
ADBHUT MATRATVA ANTENATAL SCREENING
NARENDRA C MALHOTRA
 
NRBPP .pdf
NRBPP .pdfNRBPP .pdf
NRBPP .pdf
Munewar Usman
 
An OHSS – Free Clinic : to Manage ERROR – TERROR Dr. Sharda Jain , Dr. Jyor
An OHSS – Free Clinic : to Manage ERROR – TERROR  Dr. Sharda Jain , Dr. JyorAn OHSS – Free Clinic : to Manage ERROR – TERROR  Dr. Sharda Jain , Dr. Jyor
An OHSS – Free Clinic : to Manage ERROR – TERROR Dr. Sharda Jain , Dr. Jyor
Lifecare Centre
 
Workshop on Management of poor prognosis patients
Workshop on Management of poor prognosis patientsWorkshop on Management of poor prognosis patients
Workshop on Management of poor prognosis patients
Matheus Roque
 
Prenatal Assessment of Gestational Age - Case Presentation
Prenatal Assessment of Gestational Age - Case Presentation Prenatal Assessment of Gestational Age - Case Presentation
Prenatal Assessment of Gestational Age - Case Presentation
Nawras AlHalabi
 
Neonatal jaundice - Dr. Vishnu Biradar
Neonatal jaundice - Dr. Vishnu BiradarNeonatal jaundice - Dr. Vishnu Biradar
Neonatal jaundice - Dr. Vishnu Biradar
amol1713
 

Similar to NCH_Review_Regional Level (003).pptx (20)

Mternal death review lecture by dr. evelina r. castro 102413
Mternal death review lecture by dr. evelina r. castro   102413Mternal death review lecture by dr. evelina r. castro   102413
Mternal death review lecture by dr. evelina r. castro 102413
 
Pead neonatal jaundice
Pead neonatal jaundicePead neonatal jaundice
Pead neonatal jaundice
 
Public Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy LecturePublic Health Screening: Programmes and Policy Lecture
Public Health Screening: Programmes and Policy Lecture
 
Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...
Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...
Dr. Megan Schnur - Field Experience with Mycoplasma hyosynoviae Lameness in G...
 
H1N1_Ppt.ppt
H1N1_Ppt.pptH1N1_Ppt.ppt
H1N1_Ppt.ppt
 
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...
Interesting Update on  Recurrent  Miscarriage  for Indian Gynaecologoists   D...Interesting Update on  Recurrent  Miscarriage  for Indian Gynaecologoists   D...
Interesting Update on Recurrent Miscarriage for Indian Gynaecologoists D...
 
Mu (1)
Mu (1)Mu (1)
Mu (1)
 
Mu (2)
Mu (2)Mu (2)
Mu (2)
 
Mu
MuMu
Mu
 
Mu
MuMu
Mu
 
Mu
MuMu
Mu
 
Mu
MuMu
Mu
 
Is there a place for progesterone in the management of miscarriage?
Is there a place for progesterone in the management of miscarriage?Is there a place for progesterone in the management of miscarriage?
Is there a place for progesterone in the management of miscarriage?
 
Fever in Children - A Review
Fever in Children - A ReviewFever in Children - A Review
Fever in Children - A Review
 
ADBHUT MATRATVA ANTENATAL SCREENING
ADBHUT MATRATVA ANTENATAL SCREENINGADBHUT MATRATVA ANTENATAL SCREENING
ADBHUT MATRATVA ANTENATAL SCREENING
 
NRBPP .pdf
NRBPP .pdfNRBPP .pdf
NRBPP .pdf
 
An OHSS – Free Clinic : to Manage ERROR – TERROR Dr. Sharda Jain , Dr. Jyor
An OHSS – Free Clinic : to Manage ERROR – TERROR  Dr. Sharda Jain , Dr. JyorAn OHSS – Free Clinic : to Manage ERROR – TERROR  Dr. Sharda Jain , Dr. Jyor
An OHSS – Free Clinic : to Manage ERROR – TERROR Dr. Sharda Jain , Dr. Jyor
 
Workshop on Management of poor prognosis patients
Workshop on Management of poor prognosis patientsWorkshop on Management of poor prognosis patients
Workshop on Management of poor prognosis patients
 
Prenatal Assessment of Gestational Age - Case Presentation
Prenatal Assessment of Gestational Age - Case Presentation Prenatal Assessment of Gestational Age - Case Presentation
Prenatal Assessment of Gestational Age - Case Presentation
 
Neonatal jaundice - Dr. Vishnu Biradar
Neonatal jaundice - Dr. Vishnu BiradarNeonatal jaundice - Dr. Vishnu Biradar
Neonatal jaundice - Dr. Vishnu Biradar
 

Recently uploaded

一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
xkute
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
gjsma0ep
 
Research, Monitoring and Evaluation, in Public Health
Research, Monitoring and Evaluation, in Public HealthResearch, Monitoring and Evaluation, in Public Health
Research, Monitoring and Evaluation, in Public Health
aghedogodday
 
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
Vedanta A
 
3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx
habtegirma
 
EXAMINATION OF HUMAN URINE AND FAECES.pdf
EXAMINATION OF HUMAN URINE AND FAECES.pdfEXAMINATION OF HUMAN URINE AND FAECES.pdf
EXAMINATION OF HUMAN URINE AND FAECES.pdf
Madhusmita Sahoo
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
marynayjun112024
 
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...
Media Logic
 
English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
MatSouthwell1
 
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdfnhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
Carolyn Harker
 
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTNURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
blessyjannu21
 
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
DrDevTaneja1
 
Sectional dentures for microstomia patients.pptx
Sectional dentures for microstomia patients.pptxSectional dentures for microstomia patients.pptx
Sectional dentures for microstomia patients.pptx
SatvikaPrasad
 
nurs fpx 4050 assessment 4 final care coordination plan.pdf
nurs fpx 4050 assessment 4 final care coordination plan.pdfnurs fpx 4050 assessment 4 final care coordination plan.pdf
nurs fpx 4050 assessment 4 final care coordination plan.pdf
Carolyn Harker
 
Management of Post Operative Pain: to make doctors conscious about the benefi...
Management of Post Operative Pain: to make doctors conscious about the benefi...Management of Post Operative Pain: to make doctors conscious about the benefi...
Management of Post Operative Pain: to make doctors conscious about the benefi...
Nilima65
 
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
5sj7jxf7
 
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdfData-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Jasper Colin
 
muscluskeletal assessment...........pptx
muscluskeletal assessment...........pptxmuscluskeletal assessment...........pptx
muscluskeletal assessment...........pptx
RushikeshHange1
 
The Importance of Black Women Understanding the Chemicals in Their Personal C...
The Importance of Black Women Understanding the Chemicals in Their Personal C...The Importance of Black Women Understanding the Chemicals in Their Personal C...
The Importance of Black Women Understanding the Chemicals in Their Personal C...
bkling
 
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]
Kumar Satyam
 

Recently uploaded (20)

一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
一比一原版(UoA毕业证)昆士兰科技大学毕业证如何办理
 
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
一比一原版(EUR毕业证)鹿特丹伊拉斯姆斯大学毕业证如何办理
 
Research, Monitoring and Evaluation, in Public Health
Research, Monitoring and Evaluation, in Public HealthResearch, Monitoring and Evaluation, in Public Health
Research, Monitoring and Evaluation, in Public Health
 
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdfVEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
VEDANTA AIR AMBULANCE SERVICES IN REWA AT A COST-EFFECTIVE PRICE.pdf
 
3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx3. User Guide Activity Budget Tracking App Steps to apply.pptx
3. User Guide Activity Budget Tracking App Steps to apply.pptx
 
EXAMINATION OF HUMAN URINE AND FAECES.pdf
EXAMINATION OF HUMAN URINE AND FAECES.pdfEXAMINATION OF HUMAN URINE AND FAECES.pdf
EXAMINATION OF HUMAN URINE AND FAECES.pdf
 
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdfchatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
chatgptfornlp-230314021506-2f03f614.pdf. 21506-2f03f614.pdf
 
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...
 
English Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptxEnglish Drug and Alcohol Commissioners June 2024.pptx
English Drug and Alcohol Commissioners June 2024.pptx
 
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdfnhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
nhs fpx 4000 assessment 4 analyzing a current health care problem or issue.pdf
 
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPTNURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
NURSING MANAGEMENT OF PATIENT WITH EMPHYSEMA .PPT
 
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
Digital Health in India_Health Informatics Trained Manpower _DrDevTaneja_15.0...
 
Sectional dentures for microstomia patients.pptx
Sectional dentures for microstomia patients.pptxSectional dentures for microstomia patients.pptx
Sectional dentures for microstomia patients.pptx
 
nurs fpx 4050 assessment 4 final care coordination plan.pdf
nurs fpx 4050 assessment 4 final care coordination plan.pdfnurs fpx 4050 assessment 4 final care coordination plan.pdf
nurs fpx 4050 assessment 4 final care coordination plan.pdf
 
Management of Post Operative Pain: to make doctors conscious about the benefi...
Management of Post Operative Pain: to make doctors conscious about the benefi...Management of Post Operative Pain: to make doctors conscious about the benefi...
Management of Post Operative Pain: to make doctors conscious about the benefi...
 
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
1比1制作(uofm毕业证书)美国密歇根大学毕业证学位证书原版一模一样
 
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdfData-Driven Dispensing- Rise of AI in Pharmacies.pdf
Data-Driven Dispensing- Rise of AI in Pharmacies.pdf
 
muscluskeletal assessment...........pptx
muscluskeletal assessment...........pptxmuscluskeletal assessment...........pptx
muscluskeletal assessment...........pptx
 
The Importance of Black Women Understanding the Chemicals in Their Personal C...
The Importance of Black Women Understanding the Chemicals in Their Personal C...The Importance of Black Women Understanding the Chemicals in Their Personal C...
The Importance of Black Women Understanding the Chemicals in Their Personal C...
 
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]
India Home Healthcare Market: Driving Forces and Disruptive Trends [2029]
 

NCH_Review_Regional Level (003).pptx

  • 2. What Indicators project? 15 20 28 32 16 21 27 30 0 5 10 15 20 25 30 35 ENMR NMR IMR UNDER-5 SRS-2020 INDIA BIHAR 2 19.5 3 25.5 1 10 100 TFR CBR 103 130 -10 10 30 50 70 90 110 130 MMR SRS 2020 SRS 2019
  • 3. Child Mortality Trend in Bihar 27 25 23 23 22 23 21 21 20 18 16 31 29 28 28 27 28 27 28 25 23 21 48 44 43 42 42 42 38 35 32 29 27 64 59 57 54 53 48 43 41 37 34 30 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 ENMR NMR IMR U5MR Source : SRS
  • 4. 69 58 37 59 47 30 32 28 20 U5MR* IMR NMR India (2005-2019) 2005 2010 2020 54% reduction 75 61 32 64 48 31 30 27 21 U5MR* IMR NMR Bihar (2005-2019) 2005 2010 2020 52% reduction 46% reduction 60% reduction 56% reduction 34% reduction NCH Indicators and Target Child Health Indicator India Bihar NHP 2017 SDG 2030 Neonatal Mortality Rate 20 (SRS, 2020) 21 (SRS, 2020) 16 by 2025 <12 Infant Mortality Rate 28 (SRS, 2020) 27 (SRS, 2020) 28 by 2019 - Under 5Mortality Rate 32 (SRS, 2020) 30 (SRS, 2020) 23 by 2025 ≤25
  • 5. NCH: Key Programs  Newborn Care • Special Newborn Care Unit (SNCU) at DHs • Newborn Stabilization Unit (District) at FRUs • Newborn Care Corner (NBCC) at all delivery points  Paediatric Care • Paediatric OPD • Paediatric IPD • Nutrition Rehabilitation Centre (NRC) Facility-Based Care • Home Based Newborn Care (HBNC) • Home Based Young Child Care (HBYC) • Anemia Mukt Bharat (AMB) Community-Based Care • Child Death Review • Regular Monthly Review at all levels Review Mechanism • MusQan Quality Standard
  • 7. SNCU: Admission and Outcome profile • Total Admission in the previous quarter in the Region (Sum of all districts) (Jul-Sep 2022) : 200 [CELLRANGE], 80 [CELLRANGE], 70 [CELLRANGE], 30 [CELLRANGE], 20 Inborn Outborn Private Home [CELLRANGE] 48 [CELLRANGE] 16 [CELLRANGE] 8 [CELLRANGE] 8 Inborn [CELLRANGE], 42 [CELLRANGE], 14 [CELLRANGE], 7 [CELLRANGE], 7 Outborn Discharged Referred LAMA Death [CELLRANGE], 18 [CELLRANGE], 6 [CELLRANGE], 3 [CELLRANGE], 3 Private [CELLRANGE], 12 [CELLRANGE], 4 [CELLRANGE], 2 [CELLRANGE], 2 Home
  • 8. Case type and Outcome [CELLRANGE] 20 [CELLRANGE] 5 [CELLRANGE] 3 [CELLRANGE] 2 Jaundice 30 [CELLRANGE ] 70 [CELLRANGE ] 50 [CELLRANGE ] 30 [CELLRANGE ] 20 [CELLRANGE ] 10 [CELLRANGE ] 10 [CELLRANGE ] 10 Asphyxia RDS Jaundice Seizure VLBW Preterm Others [CELLRANGE] 10 [CELLRANGE] 5 [CELLRANGE] 3 [CELLRANGE] 2 Seizure 20 Discharged Referred LAMA Death [CELLRANGE] 7 [CELLRANGE] 2 [CELLRANGE] 1 [CELLRANGE] 2 VLBW 10 [CELLRANGE] 6 [CELLRANGE] 1 [CELLRANGE] 1 [CELLRANGE] 2 Preterm 10 [CELLRANGE] 38 [CELLRANGE] 16 [CELLRANGE] 8 [CELLRANGE] 8 Asphyxia 70 [CELLRANGE] 28 [CELLRANGE] 6 [CELLRANGE] 8 [CELLRANGE] 8 RDS 50
  • 9. Birth weight and Outcome • Total Admission during the period: 200 [CELLRANGE] 68 [CELLRANGE] 16 [CELLRANGE] 8 [CELLRANGE] 8 Good Weight [CELLRANGE], 100 [CELLRANGE], 50 [CELLRANGE], 50 Good Weight (≥2500 gm) LBW (<2500gm) LBW (≤1800gm) [CELLRANGE] 28 [CELLRANGE] 6 [CELLRANGE] 8 [CELLRANGE] 8 LBW<1800gm [CELLRANGE] 28 [CELLRANGE] 6 [CELLRANGE] 8 [CELLRANGE] 8 LBW <2500 gm Discharged Referred LAMA Death
  • 10. 70 100 Rational Use of Antibiotics Newborn with Sepsis Newborn given Antibiotics [CELLRANG E], 50 [CELLRANG E], 100 [CELLRANG E], 25 [CELLRANG E], 25 Duration of Stay at SNCU >6 days 4-6 days 1-3 days <1 day Duration of Stay and Rational use of Antibiotics
  • 11. Delivery Point and SNCU Linkage [CELLRANGE] 4 [CELLRANGE] 2 [CELLRANGE] 1 [CELLRANGE] 0 [CELLRANGE] 0 [CELLRANGE] 3 [CELLRANGE] 4 [CELLRANGE] 1 [CELLRANGE] 1 [CELLRANGE] 1 [CELLRANGE] 1 [CELLRANGE] 10 [CELLRANGE] 2 [CELLRANGE] 1 [CELLRANGE] 3 [CELLRANGE] 1 [CELLRANGE] 1 [CELLRANGE] 3 [CELLRANGE] 1 [CELLRANGE] 5 [CELLRANGE] 1 [CELLRANGE] 2 [CELLRANGE] 2 [CELLRANGE] 1 [CELLRANGE] 3 [CELLRANGE] 4 [CELLRANGE] 5 [CELLRANGE] 1 [CELLRANGE] 1 [CELLRANGE] 0 0 2 4 6 8 10 12 PHC 1 PHC 2 PHC 3 PHC 4 PHC 5 PHC 6 PHC 7 PHC 8 PHC 9 PHC 10 PHC 11 PHC 12 PHC 13 PHC 14 PHC 15 PHC 16 PHC 17 PHC 18 PHC 19 PHC 20 PHC 21 PHC 22 PHC 23 PHC 24 PHC 25 PHC 26 PHC 27 PHC 28 PHC 29 PHC 30 No. of Cases referred to SNCU No. of Cases referred to SNCU
  • 13. SNCU : HR Availability 3 [CELLRANGE] 3 [CELLRANGE] 13 SNCU-1 Paediatrician GMO Nurse 3 [CELLRANGE] 3 [CELLRANGE] 13 SNCU-2 Paediatrician GMO Nurse 3 [CELLRANGE] 3 [CELLRANGE] 13 SNCU-3 Paediatrician GMO Nurse As per DoH, Bihar (Letter No. 466 Dated 12.08.2014) Posts of 1 Paediatrician, 3 GMO and 13 Grade-A Nurse have been created for each SNCU.
  • 14. SNCU Performance: Outcome [CELLRANGE] 68 [CELLRANGE] 16 [CELLRANGE] 8 [CELLRANGE] 8 SNCU-1 Discharged Referred LAMA Death [CELLRANGE] 68 [CELLRANGE] 16 [CELLRANGE] 8 [CELLRANGE] 8 SNCU-3 Discharged Referred LAMA Death [CELLRANGE] 68 [CELLRANGE] 16 [CELLRANGE] 8 [CELLRANGE] 8 SNCU-2 Discharged Referred LAMA Death No. of Treated Cases: 100 No. of Treated Cases: 100 No. of Treated Cases: 100
  • 16. Outcome of Low Birth weight (<1800gm) babies [CELLRANGE] 70 [CELLRANGE] 14 [CELLRANGE] 10 [CELLRANGE] 6 SNCU-1 [CELLRANGE] 70 [CELLRANGE] 14 [CELLRANGE] 10 [CELLRANGE] 6 SNCU-2 [CELLRANGE] 70 [CELLRANGE] 14 [CELLRANGE] 10 [CELLRANGE] 6 SNCU-3
  • 17. Outcome of Good weight (>2500gm) babies [CELLRANGE] 70 [CELLRANGE] 14 [CELLRANGE] 10 [CELLRANGE] 6 SNCU-1 [CELLRANGE] 70 [CELLRANGE] 14 [CELLRANGE] 10 [CELLRANGE] 6 SNCU-2 [CELLRANGE] 70 [CELLRANGE] 14 [CELLRANGE] 10 [CELLRANGE] 6 SNCU-3
  • 18. SNCU: Rational use of antibiotics 60 50 60 [CELLRANGE] 50 [CELLRANGE] 50 [CELLRANGE] 50 44 46 48 50 52 54 56 58 60 62 SNCU-1 SNCU-2 SNCU-3 No. of Sepsis Cases No. of babies treated with antibiotics
  • 19. Functionality and utilization of CPAP machine Sl. No. Name of SNCU No. of CPAP Machine Available No. of CPAP Machine Functional No. of babies with birth weight <1800gm No. of babies with <34 Weeks of gestation No. of babies with RDS admitted during the period No. of babies with RDS managed using CPAP during the period 1 2 3 4
  • 20. SNCU Performance: Other key areas Review Point SNCU-1 SNCU-2 SNCU-3 SNCU-4 1. Daily Round of Paediatrician in all 3 shifts (Yes/No) Morning Shift Yes Yes Yes No Evening Shift Yes Yes Yes No Night Shift Yes Yes Yes No Round Register maintained properly No Yes Yes No 2. Equipment Mapping of equipment completed Yes Yes Yes No 3. Availability of drugs and logistics No Stockouts during the period (Yes/No) Yes Yes Yes No 4. Availability of Lab investigations (Serum bilirubin, Plasma glucose, Serum creatinine, Blood count, Platelet, C reactive protein, Prothrombin time, Blood gas analysis with PH measurement analysis.) All Lab investigations available Yes Yes Yes Yes
  • 22. 8 5 5 5 All NBSU LBW (<2500 gm) Birth Weight <1800 gm Jaundice Cases Others NBSU: Admission Profile Sl. No. Name of NBSU Admission LBW (<2500gm) Birth Weight (<1800gm) Jaundice Cases Others 1 NBSU-1 2 NBSU-2 3 NBSU-3 4 NBSU-4 5 NBSU-5 6 NBSU-6 7 NBSU-7
  • 23. 8 5 5 5 All NBSU Discharged Referred LAMA Death NBSU: Outcome Profile Sl. No. Name of NBSU Admission Vs Outcome Functional (Yes/No) Total Admission Discharge Referred LAMA Death 1 NBSU-1 10 4 (80%) 3 (30%) 2 (20%) 1 (10%) 2 NBSU-2 3 NBSU-3 4 NBSU-4 5 NBSU-5 6 NBSU-6 7 NBSU-7
  • 25. NBCC: Admission Profile Sl. No. Name of District Weight and Maturity Total Live Birth LBW (<2500gm) Birth Weight (≤2000gm) Birth Weight <1800gm) <34 Weeks <37 Weeks Cases managed at NBCC Cases Referred to higher centre Desired Action Initial management at NBCC followed by quality HBNC Initial management at NBCC followed by quality HBNC Referral after stabilization 1 District-1 2 District-2 3 District-3 4 District-4 5 District-5 6 District-6 7 District-7
  • 26. Management of neonatal complications at NBCC 14 15 14 15 [CELLRANGE] 5 [CELLRANGE] 6 [CELLRANGE] 5 [CELLRANGE] 8 [CELLRANGE] 3 [CELLRANGE] 4 [CELLRANGE] 2 [CELLRANGE] 3 [CELLRANGE] 2 [CELLRANGE] 2 [CELLRANGE] 3 [CELLRANGE] 5 0 2 4 6 8 10 12 14 16 District-1 District-2 District-3 District-4 NBCC Performance Sum of Live Births at all Delivery Points No. of Cases identified with neonatal complications Cases manged at NBCC Cases Referred
  • 27. NBCC: Do’s and Don’ts Do’s • Always wash your hands before handling the baby • Rooming in of baby with the mother • Keep the baby with the mother • Keep the baby warm • Take extra care to maintain baby’s temperature is preterm and LBW baby • Keep the cord dry and clean • Breast fed the baby exclusively • Early initiation of breast feeding is essential for a good reflex action • Any signs/symptoms of complications must be referred and attended to by a doctor • The care provider should observe every 2 hours in the first 6 hours and every 6 hours from 6-24 hours after delivery • If the newborn is LBW then at least three additional visits should be ensured Don’ts • Do not keep all babies as a routine under the radiant warmer • Do not delay breast feeding beyond half an hour as that may lead to rapid decrease in suckling reflex of the rapid decrease in suckling reflex of the baby • Do not use prelacteals even water • Do not apply anything on the cord • Do not bathe the newborn for 24hrs after birth • Do not forget to undertake routine checkup
  • 29. NRC: ELA Vs Admission 60 50 60 60 60 [CELLRANGE] 50 [CELLRANGE] 50 [CELLRANGE] 50 [CELLRANGE] 50 [CELLRANGE] 50 44 46 48 50 52 54 56 58 60 62 NRC-1 NRC-2 NRC-3 NRC-4 NRC-5 ELA Admission
  • 30. NRC: Average Duration of Stay 21 14 10 5 14 0 5 10 15 20 25 NRC-1 NRC-2 NRC-3 NRC-4 NRC-5 Average Duration of Stay
  • 31. NRC: Availability of Diet and Drugs Sl. No. Name of NRC Diet being provided as per the guideline Drugs and other logistics available as per the guideline 1 NRC-1 Yes Yes 2 NRC-2 No Yes 3 NRC-3 Yes Yes 4 NRC-4 Yes Yes 5 NRC-5 Yes No
  • 33. HBNC: Performance 3,000 3,000 3,000 3,000 3,000 5,000 5,000 5,000 5,000 5,000 3,000 2,500 2,700 3,000 3,000 4,000 5,000 4,000 3,000 3,000 [CELLRANGE] 200 [CELLRANGE] 150 [CELLRANGE] 125 [CELLRANGE] 100 [CELLRANGE] 100 0 1000 2000 3000 4000 5000 6000 District-1 District-2 District-3 District-4 District-5 #REF! No. of ASHA Live Birth No. of ASHAs having new HBNC Kit Cases visited by ASHA Sick Children identified by ASHA
  • 34. HBNC: Supportive Supervision 5,000 5,000 5,000 5,000 5,000 [CELLRANGE] 4,000 [CELLRANGE] 5,000 [CELLRANGE] 4,000 [CELLRANGE] 3,000 [CELLRANGE] 3,000 [CELLRANGE] 400 [CELLRANGE] 250 [CELLRANGE] 300 [CELLRANGE] 500 [CELLRANGE] 450 [CELLRANGE] 10 [CELLRANGE] 15 [CELLRANGE] 30 [CELLRANGE] 25 [CELLRANGE] 50 [CELLRANGE] 5 [CELLRANGE] 3 [CELLRANGE] 10 [CELLRANGE] 12 [CELLRANGE] 25 1 10 100 1,000 10,000 District-1 District-2 District-3 District-4 District-5 Live Birth Cases visited by ASHA Cases visited by ASHA Faciliatators Cases vistited by Block level Officers Cases vistited by district level Officers
  • 35. HBNC • Availability of HBNC Kit • Quality of home visit by the ASHA using HBNC Kit • Supportive Supervision by ASHA Facilitators • Timely payment • Review of the program at all levels
  • 36. Home Based Young Child Care (HBYC)
  • 37. Training of ASHAs on HBYC 2,000 2,500 3,000 2,000 2,300 [CELLRANGE] 1,500 [CELLRANGE] 1,200 [CELLRANGE] 2,000 [CELLRANGE] 2,000 [CELLRANGE] 230 - 500 1,000 1,500 2,000 2,500 3,000 3,500 District-1 District-2 District-3 District-4 District-5 No. of ASHA-Target No. of ASHA-Trained
  • 38. HBYC: Visit by ASHA and Payment 2,000 2,500 3,000 2,000 2,300 [CELLRANGE] 1,500 [CELLRANGE] 1,200 [CELLRANGE] 2,000 [CELLRANGE] 2,000 [CELLRANGE] 230 [CELLRANGE] 1,000 [CELLRANGE] 1,000 [CELLRANGE] 1,500 [CELLRANGE] 1,500 [CELLRANGE] 100 - 500 1,000 1,500 2,000 2,500 3,000 3,500 District-1 District-2 District-3 District-4 District-5 ASHA-Trained on HBYC ASHA-Started visit ASHA-Received Payement for atleast 1 case
  • 40. CDR • Reporting: Timely, Completeness, Correctness • Review of reported cases as per the CDSR guideline • Online Reporting on the MPCDSR Portal
  • 41. CDR: Reporting and Review 500 300 400 500 500 [CELLRANGE] 25 [CELLRANGE] 55 [CELLRANGE] 22 [CELLRANGE] 35 [CELLRANGE] 32 [CELLRANGE] 12 [CELLRANGE] 12 [CELLRANGE] 13 [CELLRANGE] 15 [CELLRANGE] 15 [CELLRANGE] 5 [CELLRANGE] 6 [CELLRANGE] 7 [CELLRANGE] 8 [CELLRANGE] 9 1 10 100 1000 District-1 District-2 District-3 District-4 District-5 ELA-Child Death Reported on HMIS Reported on CDR Format Detailed Investigation
  • 42. MusQan: Gap Assessment Sl. No. Name of District Credential (Login ID and Password) Received from the state (Yes/No) Online Reporting started (Yes/No) 1 District-1 Yes Yes 2 District-2 Yes No 3 District-3 Yes Yes 4 District-4 No No 5 District-5 Yes Yes
  • 44. Progress on MusQan initiative Sl. No. Name of District Facility identified for QI as per MusQan Baseline Assessment Completed using MusQan Checklist Nodal Officer Nominated (Yes/No) 1 District-1 Yes Yes Yes 2 District-2 Yes No Yes 3 District-3 Yes Yes Yes 4 District-4 No No Yes 5 District-5 Yes Yes Yes